HIGH BLEEDING RISK (HBR)
Clinical trials for HIGH BLEEDING RISK (HBR) explained in plain language.
Never miss a new study
Get alerted when new HIGH BLEEDING RISK (HBR) trials appear
Sign up with your email to follow new studies for HIGH BLEEDING RISK (HBR), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Trial tests cutting blood thinner time to protect heart patients
Disease control Not yet recruitingThis study is for people who have had a heart attack and received a stent, but are at high risk for both future clots and serious bleeding. It will test if using a special stent and only one month of strong blood thinners is as safe and effective as using standard stents with a f…
Matched conditions: HIGH BLEEDING RISK (HBR)
Phase: NA • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Major heart study aims to prevent bleeding and clots in High-Risk stent patients
Knowledge-focused Not yet recruitingThis study aims to create better safety guidelines for blood-thinning medications given after heart stent surgery. It will follow 3,500 patients at high risk of bleeding complications for one year to see how well they tolerate the standard two-drug therapy and to test a new risk-…
Matched conditions: HIGH BLEEDING RISK (HBR)
Sponsor: Shenyang Northern Hospital • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC